tiprankstipranks
Singular Genomics Systems (OMIC)
NASDAQ:OMIC
US Market

Singular Genomics Systems (OMIC) Income Statement

Compare
80 Followers

Singular Genomics Systems Income Statement

Last quarter (Q3 2024), Singular Genomics Systems's total revenue was $406.00K, a decrease of -12.12% from the same quarter last year. In Q3, Singular Genomics Systems's net income was $-16.80M. See Singular Genomics Systems’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.91M$ 765.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -558.00K$ -24.00K$ -1.13M$ -639.00K$ -350.00K
Operating Expenses
$ 102.24M$ 93.46M$ 61.28M$ 27.53M$ 12.77M
Depreciation and Amortization
$ 7.22M$ 6.03M$ 1.13M$ 639.00K$ 350.00K
EBITDA
$ -86.50M$ -84.08M$ -60.55M$ -26.39M$ -11.96M
Operating Income
$ -102.80M$ -93.49M$ -61.28M$ -27.53M$ -12.77M
Other Income/Expenses
$ 7.98M$ 2.61M$ -37.49M$ -411.00K$ 446.00K
Pretax Income
$ -94.82M$ -90.88M$ -98.77M$ -27.95M$ -12.32M
Net Income
$ -94.82M$ -88.27M$ -98.89M$ -28.66M$ -12.34M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -39.08$ -37.22$ -40.95$ -12.41$ -5.34
Diluted EPS
$ -39.08$ -37.22$ -40.95$ -12.41$ -5.34
Weighted Average Shares Outstanding
2.43M 2.37M 2.41M 2.31M 2.31M
Weighted Average Shares Outstanding (Diluted)
2.43M 2.37M 2.41M 2.31M 2.31M
Currency in USD

Singular Genomics Systems Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis